000			01730nam a2200133Ia 4500
008			220615s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aPersonalized Medicine in the Field of Inflammatory Skin Disorders
546			_aEnglish[eng]
650			_asea-buckthorn seed oil||long-chain fatty acids||skin dysplastic keratinocytes||UVA||CD36||SR-B2||atopic dermatitis||eczema||JAK inhibitors||systematic review||meta-analysis||evidence-based medicine||immune-mediated skin diseases||target therapy||skin conditions and systemic inflammatory diseases||systemic sclerosis||biomarker||calumenin||S100A6||cytohesin 2||cannabinoids||inflammation||gut-lung-skin barrier||signaling pathways||inflammatory biomarkers||psoriasis vulgaris||prevalence||comorbidities||risk factors||systemic lupus erythematous||lupus nephritis||lipid peroxidation||DNA oxidation||oxidized proteins||carbohydrate oxidation||antioxidative stress strategies||biomarkers||IgY||psoriatic dermatitis||imiquimod||C57 BL/6 mice||alginate||biomaterial||dressing||fibers||hydrogel||nanofibers||commercially available||wound care||wound healing||cutaneous melanoma||epigenetic regulation||drug resistance||therapeutic targets||epigenetic therapy||immune response||Sutton nevi||halo nevi||skin tumor||psoriasis||proteome analysis||estrogen||menopause||cSCC||AK||sialylation||sialyltransferase||sialidase||COVID-19||pyoderma gangrenosum||immunosuppression||cyclosporine||corticosteroids||autoinflammatory disease||androgenic alopecia||clinical trial||hair density||platelet-rich plasma||n/a
700			_aTampa, Mircea||Neagu, Monica||Caruntu, Constantin||Georgescu, Simona Roxana
856			_uhttps://mdpi.com/books/pdfview/book/5182
942			_cEB
999			_c16205 _d16205